#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Diffuse large B-cell lymphoma Encephalitis autoimmune Type IIa hyperlipidaemia Fibrous dysplasia of bone Interstitial lung disease Autoimmune hepatitis Loss of consciousness Liposarcoma Necrotising enterocolitis neonatal Philadelphia positive chronic myeloid leukaemia Thrombotic thrombocytopenic purpura Deafness bilateral Idiopathic inflammatory myopathy Fms-like tyrosine kinase 3 positive Pleomorphic leiomyosarcoma More trials…

    Learn about Rare Diseases

    Erdheim-Chester disease Osteosarcoma Congenital nephrogenic diabetes insipidus Shprintzen-Goldberg syndrome – Basic Information Hypereosinophilic syndrome – Diagnostics Hepatic angiosarcoma – Basic Information Cytokine release syndrome – Treatment Pulmonary fibrosis – Life with Disease Primary immunodeficiency syndrome – Basic Information Leiomyosarcoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Mosliciguat Telitacicept Olopatadine Hydrochloride Pristinamycin Pp1493 Exidavnemab GAXILOSE M-(18F)-Fluorobenzylguanidine Ocrelizumab Db-Oto-5 Clotrimazole Specific Nucleic Acid Sna-Her1 Phenylbutyrate Azd5462 Cariprazine Imatinib Mesilate Gns561 Sonidegib Oxycodone Hydrochloride Mk-4830 More therapies…

    Learn about Your Condition

    Post-acute COVID-19 syndrome Adenocarcinoma Eosinophilic oesophagitis Rectal cancer stage III Supranuclear palsy Acute myeloid leukaemia Iron deficiency Arteriosclerosis Polycystic ovarian syndrome Nodal osteoarthritis Head and neck cancer Haemorrhagic stroke Immunodeficiency congenital Osteosarcoma recurrent Encephalitis autoimmune More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Colitis ulcerative

  • Study on the Long-Term Effects of TEV-48574 (Duvakitug) for Adults with Moderate to Severe Ulcerative Colitis or Crohn’s Disease

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Colitis ulcerative
    • Crohn’s disease
    Investigated Drugs:
    • Duvakitug
    Austria Bulgaria Czechia Germany Hungary Italy +4

  • Study of Tulisokibart for Patients with Moderately to Severely Active Ulcerative Colitis

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Tulisokibart
    Czechia France Hungary Poland

  • Study on the Effects of Fecal Microbiome and Fecal Microbiome Filtrate Capsules for Patients with Active Ulcerative Colitis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Allogeneic Faecal Microbiota, Pooled
    • Metronidazole
    • Vancomycin
    Germany

  • Study on the Use of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Treating Ulcerative Colitis in Patients

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells Expanded
    • Sodium Chloride
    Denmark

  • Study on the Effects of Hyperbaric Oxygen Therapy for Patients with Moderate-to-Severe Ulcerative Colitis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Oxygen
    The Netherlands

  • Study on Long-Term Safety of Adalimumab for Children with Ulcerative Colitis Who Completed Previous Study

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Adalimumab
    Poland Slovakia
Previous Page
1 … 12 13 14 15 16 … 20
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!